No Patient Left Behind: The Vital Role of Accurate Translation in Clinical Research
In clinical research, translation is essential. Every patient deserves to fully understand their consent. Unfortunately, many critical documents like informed consent forms and trial instructions are inadequately translated, leading to confusion, misinformed choices, and potential safety risks.
The EU Clinical Trials Regulation was a game-changer. It requires that informed consent materials be culturally and linguistically appropriate for the target population. Participants who misunderstand procedures or risks may drop out, skew results, or suffer avoidable harm.
This regulation requires that these documents be written in non-technical, simple, clear language understandable to laypersons. This is critical because clinical trials often involve complex medical language that can be difficult to understand. By using plain language and ensuring that the translations are clear and culturally sensitive, clinical trial sponsors and investigators can ensure that patients are making decisions with all the necessary information.
Moreover, the regulation emphasizes that all trial-related documents must be translated into the local language(s) of the participants, which can vary from region to region. A failure to do so could lead to regulatory penalties, delays in trial approval, or worse, patient safety incidents caused by miscommunication.
Challenges in Translation for Clinical Trials
The complexity of clinical trial translation lies in its precision and accuracy. Medical documents contain specialized terminology that requires subject matter expertise—something that goes beyond just being fluent in a language. Translators must have experience in medical language to ensure proper interpretation of terms, procedures, and risks. Additionally, translators must adhere to regulatory guidelines that may vary from country to country.
Another challenge is the localization of materials for patients. For example, a term that is commonly understood in one country might have a different meaning or cultural context in another. Localization ensures that the trial is not only understandable but also relevant to the target audience. This means accounting for local healthcare practices, terminology, and patient expectations.
How to Ensure Accurate Translation in Clinical Trials
Collaborating with Specialized Medical Translators
Translators should have experience in medical and clinical trial terminology and be familiar with regulatory guidelines. Partnering with translation companies that specialize in life sciences can help ensure high-quality translations.
Using Translation Memory Tools
Translation Memory (TM) tools improve consistency by allowing translators to reuse previously translated phrases, ensuring uniformity throughout the trial.
Cultural Adaptation
Clinical trial materials must be translated and adapted to the cultural context of the target population. Working with local experts can help ensure the language is clear and culturally appropriate.
Proofreading and Verification
After translation, documents should undergo proofreading and verification to check for grammatical errors, clarity, and consistency with the original material.
At Janus Worldwide, we understand the complexities of clinical trial translation and provide specialized localization services tailored to the life sciences industry. Contact us today to learn how we can assist with your translation needs.


